Insight
FDA Issues Draft Guidance on AI-Enabled Medical Devices
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
3 minute read | January.07.2025

by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
3 minute read | January.07.2025
by Aravind Swaminathan and Adele Harrison
20 minute read | January.30.2025
by Jamie Moore, SeoJung Park, Eric Wall and Kristy Hart
8 minute read | January.30.2025
by Aravind Swaminathan, Jenna Magan, Joseph C Santiesteban, John Palmer and Sean Yates
2 minute read | January.30.2025
A recent cyberattack on a Michigan township has exposed weaknesses in the bond-closing process.
by Sarah Schaedler and Haley Flora
4 minute read | January.31.2025
1 hour watch | January.29.2025
2 minute read | July.15.2025
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
2 minute read | January.13.2025
The FDA issued draft guidance on assessing AI model credibility for drug safety, effectiveness, and quality in regulatory decisions.
by Ignacio Sandoval
2 minute read | January.16.2025
The SEC has approved FINRA's 6500 rule series, which governs the Securities Lending and Transparency Engine (SLATE).
4 hour read | January.16.2025
by Sulina Gabale, Amanda Lawrence, Sasha Leonhardt, Elizabeth McGinn and Sherry-Maria Safchuk
6 minute read | July.07.2025
Montana and Connecticut join other states in removing broad GLBA exemptions for financial firms under privacy laws.
by Benedikt Migdal, Marianna Urban and Ilona Schütz
3 minute read | January.09.2025